Colgate-Palmolive Company is a global consumer products company with a market capitalization of $63.82 billion. Despite a 21% drop from its 52-week high, the stock has underperformed the S&P 500 Index, declining by 7.9% over the past three months. In its third-quarter results, net sales increased 2% year-over-year to $5.13 billion, with EPS topping analyst estimates at $0.91. While the stock dropped 2.7% intraday on Nov. 3 due to slow growth, Wall Street analysts have a “Moderate Buy” rating with a mean price target of $86.71, indicating a 9.5% upside potential.

Read more at Barchart: Is Colgate-Palmolive Stock Underperforming the S&P 500?